Predictions
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€5.34
30.05.23
30.05.23
-
30.05.24
30.05.24
14.61%
24.07.23
24.07.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.02
30.05.23
30.05.23
-
30.05.24
30.05.24
5.00%
17.07.23
17.07.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.60
16.04.23
16.04.23
-
16.04.24
16.04.24
-16.11%
30.05.23
30.05.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.03.23
24.03.23
-
24.03.24
24.03.24
12.58%
18.05.23
18.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€36.73
11.03.23
11.03.23
€30.00
11.03.24
11.03.24
0.48%
18.04.23
18.04.23
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€26.85
14.03.22
14.03.22
€40.00
14.03.23
14.03.23
36.78%
11.03.23
11.03.23
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.32
14.11.22
14.11.22
-
14.11.23
14.11.23
-8.52%
24.02.23
24.02.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€10.10
21.02.22
21.02.22
-
21.02.23
21.02.23
-35.47%
22.02.23
22.02.23
Could be very worthwhile Investment >20% year
New Gold Inc.
Start price
Target price
Perf. (%)
€1.51
08.02.22
08.02.22
€1.85
08.02.23
08.02.23
-35.14%
09.02.23
09.02.23
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Nexgen Energy Ltd
Start price
Target price
Perf. (%)
€3.69
05.02.22
05.02.22
€6.00
05.02.23
05.02.23
12.57%
06.02.23
06.02.23
Could be worthwhile Investment >10% per year
Fair valuation
positive Cash Flow expected
Mag Silver Corp.
Start price
Target price
Perf. (%)
€12.89
17.10.22
17.10.22
-
17.10.23
17.10.23
-2.21%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€4.46
06.11.21
06.11.21
-
06.11.22
06.11.22
-34.65%
07.11.22
07.11.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€2.41
23.08.22
23.08.22
-
23.08.23
23.08.23
21.54%
01.11.22
01.11.22
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Mag Silver Corp.
Start price
Target price
Perf. (%)
€17.26
30.10.21
30.10.21
-
18.01.25
18.01.25
-25.35%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€8.29
09.08.22
09.08.22
-
09.09.22
09.09.22
-3.35%
10.09.22
10.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model